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RESISTANCE TO THE SECOND-GENERATION ANTICOAGULANT 
RODENTICIDES 
MOGENS LUND, Danish Pest Infestation Laboratory, Skovbrynet 14, 2800 Lyngby, Denmark 
ABSTRACT:  The second-generation anticoagulants, difenacoum, bromadiolone and brodifacoum, have taken 
over a considerable part of the rodenticidal market during the last six to eight years.  This is partly 
due to the higher efficiency against a larger spectrum of rodent pest species and partly to the increas-
ing problem of physiological resistance to the older anticoagulants.  Resistance of practical importance 
has, however, now been encountered to difenacoum and bromadiolone in Europe, i.e., UK and Scandinavia. 
Brodifacoum, in spite of the evidence of a somewhat increased tolerance in some commensal rodent popu-
lations, still must be considered a highly effective rodenticide against almost all important rodent 
pest species. 
Research leading to the synthesis of similar potent anticoagulant molecules or other slow-acting 
rodenticides should be encouraged in order to cope with the possible development of resistance also to 
brodifacoum in the future. 
INTRODUCTION 
Rodent resistance to warfarin and other "first-generation anticoagulants" has now been known for 
25 years, the first population of warfarin-resistant brown rats (Rattus norvegicus) being discovered in 
Scotland in 1958 (Boyle 1960).  Today resistance to these anticoagulants has been established in all 
the three major commensal species in UK and USA (Greaves et al. 1973, Dodsworth 1961, Greaves et al. 
1976, Jackson et al. 1972, Jackson et al. 1979); in brown rats in Denmark (Lund 1964); in brown rats 
and house mice (Mus musculus) in Holland (Ophof et al. 1969; pers. comm. 1982); in both rat species in 
France (Desideri et al. 1978); in roof rats (R. rattus) in Australia and Malaysia (Saunders 1978, Lam 
et al. 1982); and in house mice in Sweden, Belgium, Finland and Canada (Lund et al.  1978, pers. comm. 
1982, Cronin 1979, Morgan et al. 1979). 
Typically, the rodent populations have shown cross--resistance to the other anticoagulants in use 
up to 1975, and the "level" of resistance seems to have been inversely closely correlated with the 
relative toxicity of the compounds in question. 
The more potent "second-generation" anticoagulant--difenacoum, bromadiolone and brodifacoum--were 
registered and marketed in the mid-seventies primarily as an attempt to improve this situation.  But 
after a very short time the initial success of two of these compounds was shaken by reports indicating 
that rodent populations had also shown resistance to difenacoum and bromadiolone. 
RESISTANCE TO DIFENACOUM 
Difenacoum (3-(3-p-diphenyl-1,2,3,4-hydronaphth-l-yl)-4-hydroxycoumarin) was synthesized by Sorex 
Ltd (Hadler et al. 1975) and marketed by ICI in 1975. The acute LD50 for R. norvegicus varies in the literature between 1.8 mg/kg (Bull et al. 1976) and 3.5 mg/kg (DuboCK 1980).  Already in 1976 the first 
case of resistance was detected in UK where 6 of 72 brown rats from five farms survived a 6-day feeding 
test (Redfern et al. 1978).  In 1980 resistant populations were established in a larger area in Southern 
England (Hampshire).  No more than a 33% reduction in rat numbers could be achieved in a two weeks' 
treatment in six farmsteads (Greaves et al. 1982a).  Of 202 rats trapped on 42 farms in this district 
85% were resistant to warfarin and 14% to difenacoum, and only those resistant to warfarin also showed 
difenacoum-resistance (Greaves et al. 1982b).  If the concentration in the bait was raised from 0.005% 
to 0.025% a complete kill was obtained, and the resistance factor is presumed to be around five. 
Difenacoum-resistance has not been detected in warfarin-resistant rat populations in Wales and Scotland, 
confirming the view that different genetic types of resistance occur.  It is suggested (Greaves et al. 
1982a) that either the penetrance of difenacoum-resistance is lower than that of warfarin-resistance or 
that only animals homozygous for the warfarin-resistance gene are also resistant to difenacoum.  Other 
reports indicate resistance in roof rats in France (Desideri 1979) and in UK (Redfern et al. 1978). 
House mice from suspected resistant field populations in UK survived a 21-day feeding test on 0.005% 
difenacoum consuming doses up to 147 mg/kg (Rowe et al. 1981). 
RESISTANCE TO BROMADIOLONE 
Bromadiolone (3(3-(4'-bromo(l,1'-biphenyl)-4-yl)-3-hydroxy-l-phenyl-propyl)-hydroxy-2H-l-
benzopyran-2-1) was developed by the Lipha Company in Lyon, France, in the mid-seventies and is now one 
of the preferred anticoagulants for the control of the commensal species in many countries. The acute 
LD50 for R. norvegicus varies from 0.65 mg/kg (Meehan 1978) to 1.125 mg/kg (Grand 1976).  Recently, brown rat populations in UK are reported to be slightly resistant to this compound in spite of its 
being effective against difenacoum-resistant strains (Greaves et al. 1982c). Field tests resulted in 
only 14% mortality after 14 days of baiting and 83% after 35 days compared with the complete kill 
typically obtained with 0.005% warfarin in similar treatments of susceptible rat populations (Drummond 
et al. 1973). Similarly, house mouse populations in UK--difficult to control efficiently—-were sampled 
and tested in the lab revealing a substantial resistance, as no more than about 57% mortality could be 
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achieved in a 21-day feeding test on 0.005% bromadiolone. Individuals survived doses up to 410 mg/kg 
(Rowe et al. 1981).  In Canada evidence of increased tolerance to bromadiolone has been found in house 
mice from Toronto (Siddigi et al. 1982). 
RESISTANCE TO BRODIFACOUM 
Brodifacoum (3-(3-(4'-bromobiphenyl-4-yl )-l ,2,3,4-tetrahydronaphth-l-yl)-4-hydroxycoumarin) is the 
newest and most potent of the second-generation anticoagulants, synthesized in 1977 by Sorex Ltd., and 
recently marketed in several countries by ICI for the control of a wide range of commensal as well as 
field rodent species.  The LD50 value for Rattus norvegicus is reported to be 0.22 mg/kg.  At present no resistance of practical importance has been encountered in any country, and very few of the world's 
most important pest species have shown a natural tolerance to this compound (e.g., Acomys cahirinus and 
Meriones shawi).  Previous reports have indicated a high degree of efficiency of 0.0005% brodifacoum 
against populations of warfarin-resistant brown rats in UK and USA (Rennison et al. 1978, Apperson 
et al. 1981), but lately British experts have found it difficult to explain that baiting periods up to 
73 days have been needed in order to obtain complete mortality with 0.002% brodifacoum against brown 
rats on five farmsteads in Hampshire (Greaves et al. 1982c). Tests at the Tolworth Laboratory have 
revealed that difenacoum-resistant brown rats show a two to three times higher tolerance to brodifacoum 
than susceptible laboratory strains (Res. Dev. Rep. 1983). In roof rats and house mice a complete kill 
is usually achieved after only one day's feeding on 0.005% brodifacoum (Dubock et al. 1978), but re-
cently house mice have shown increased tolerance to this compound in laboratory tests in Canada (Siddiqi 
et al 1982). 
RESULTS OF RESISTANCE TESTS WITH SECOND-GENERATION ANTICOAGULANTS IN DENMARK 
In Denmark warfarin-resistance in brown rat populations was detected in 1962, and since that time 
rats from 30 municipalities have survived the WHO standard resistance test.  Coumatetralyl, another 
hydroxycoumarin anticoagulant, was quite effective for four to five years and was the only anticoagulant 
used in the western part of the country from 1972 to 1976.  Today resistance to coumatetralyl is found 
in 19 municipalities and in 32% of the rats trapped in this region, compared with 41% to warfarin 
(Table 1).  Difenacoum was introduced in 1976, but has only been used in small quantities and particu-
larly where satisfactory results could not be achieved by means of calciferol.  Bromadiolone, introduced 
in 1979, soon became the preferred anticoagulant in most parts of Denmark. 
In a continuous-resistance survey, rats trapped in various parts of the country were--from 1979 as 
a routine--first tested on 0.005% warfarin or 0.03% coumatetralyl; and after an observation period of 
at least three weeks, most of the survivors were then submitted to a 6-day test on 0.005% bromadiolone, 
and, if possible, after another three weeks again on 0.005% difenacoum and eventually on 0.005% 
brodifacoum. In a few tests the concentration of bromadiolone was increased five times (to 0.01%, in 
consequence of the fact that baits of this concentration had been registered for the control of 
especially resistant rats. In a single test brodifacoum was administered at a ten times lower concen-
tration (0.0005%) in order to reveal  the possible presence of a slightly increased tolerance to this 
compound.  The results are given in Tables 1  and 2.  The first case of difenacoum-resistance was esta-
blished three years after the introduction (1979), and at the end of 1983 six municipalities appear to 
have difenacoum-resistant rats. 
Survivors from bromadiolone-resistant tests were found one year after introduction (1980), and at 
the end of 1983 ten municipalities in Jutland and West-Funen had resistance problems.  Of 323 rats 
tested, 95 survived doses up to 47 mg/kg.  Some evidence of cross-resistance was seen, as survivors 
from warfarin/coumatetralyl tests showed 63.4% resistance compared with 15.7% resistance in rats not 
previously selected by these anticoagulants in the laboratory.  Mortality was increased significantly 
if the concentration in the bait was raised five times; a complete kill could, however, still not be 
achieved.  Of 32 bromadiolone- or difenacoum-resistant rats, none survived a 6-day feeding test on 
0.005% brodifacoum; and even at a concentration as low as 0.0005%, no indication of increased tolerance 
could be observed. 
The roof rat is a rare species in Denmark today and no evidence of resistance has been registered. 
Prior to the introduction of bromadiolone the house mouse was not routinely controlled by anti-
coagulants in this country, and no sign of resistance has been detected.  House mice trapped in the 
Swedish town of Mai mo, very close to Copenhagen, where warfarin had been used as the only compound for 
decades, were, however, found highly resistant when submitted to 21-day feeding tests on 0.025% 
warfarin at our laboratory in 1977.  This strain has been kept at the laboratory since that time and 
used routinely for testing new anticoagulants.  Results of tests with this strain and with mice trapped 
in Denmark are given in Tables 3-7. 
Where 100% mortality could be obtained in 21-day feeding tests on 0.025% warfarin with Danish 
mice, only 50% of the Swedish mice were killed with survivors consuming up to 700 mg/kg. Bromadiolone 
(0.005%) produced a lower mortality in Swedish mice after ten; days' feeding than in Danish mice after 
one day, but doubling the concentration increased the mortality six times.  Difenacoum (0.005%) gave a 
complete kill in tests with Danish mice after four days’ feeding, but only 91% mortality in Swedish 
mice after 21 days.  Finally, brodifacoum at a concentration of 0.005% gave complete kill in Danish 
mice in a 1-day feeding period and the same result in Swedish mice after a 3-day feeding. If the 
concentration was reduced 10 times, a 100% mortality could still be achieved in Danish mice after a 2-
day feeding period, but now all Swedish mice survived.  Swedish mice previously tested on bromadiolone 
also showed a higher tolerance to brodifacoum than those not tested before, indicating some degree of 
cross-resistance (Table 6 and 7). 
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Table 1.  Showing when and where resistance to various anticoagulants was first detected in Denmark 
(the names are indicating Danish municipalities) 
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Table 2.  The effect of bromadiolone, difenacoum and brodifacoum on brown rats (Rattus Norvegicus) 
trapped in various municipalities in western Denmark.  Feeding period:  6 days. 
 
Table 3.  The effect of warfarin on house mice (Mus musculus) from Denmark or southern Sweden. 
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Table 5.  The effect of difenacoum on house mice (Mus musculus) from Denmark or southern Sweden. 
 
Table 6.  The effect of brodifacoum on house mice (Mus musculus) from Denmark or southern Sweden. 
     Concentration   Origin Feeding      No. of     Mortality     Average Amount Consumed (Range)      
  of Mice Period  Mice %          mg/kg 
(Days)     Lethal      Non lethal 
Table 7.  The effect of 0.005% brodifacoum on Danish house mice (Mus musculus) and Swedish house mice 
resistant to bromadiolone. 
 
 
CONCLUSIONS 
As resistance to two of the three second-generation anticoagulants, difenacoum and bromadiolone, 
has become a problem of practical importance in some countries shortly after their introduction, this 
must call for attention in those countries still fighting resistance "only" to the first-generation 
anticoagulants.  In spite of brodifacoum still being highly effective, certain findings of increased 
tolerance also to this compound should be taken as a warning not to rely too much on this single 
rodenticide to solve our resistance problems in the future.  It is recommended to concentrate research 
on the synthesis of similar potent anticoagulants or on the development of other slow-acting rodenti-
cides. 
The importance of resistance to the second-generation anticoagulants may be indicated by the 
situation revealed in British rodent surveys in 1970 and 1980:  The proportion of rat-infested farm-
steads in Hampshire, where difenacoum had been the rodenticide of choice since 1975, increased in this 
period from 45% to 95% (Greaves et al. 1982c). 
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